Northern Genesis Acquisition Corp. III
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Michael M. B. Hoffman
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 4801 Main Street Kansas City MO United States of America 64112
- CIK
- 0001843249
- Website
- northerngenesis.com
- Similar Companies
- Business
- Northern Genesis Acquisition Corp. III Northern Genesis Acquisition Corp. III is a blank check company whose principal business activity involves effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company focuses its acquisition efforts primarily on opportunities in sectors such as automotive and transportation including electric vehicles and sustainable solutions; technology encompassing software, hardware, fintech, healthtech and logistics; consumer products emphasizing sustainability, health and wellness; healthcare involving biotech, telehealth, medical devices and personalized medicine; and sustainability and renewables covering solar energy, wind energy and waste management. It offers services including investment opportunities in high-growth private companies through public markets, mergers and acquisitions facilitation with due diligence and valuation, strategic guidance on financial management, marketing, market entry and regulatory compliance for portfolio companies post-merger, and capital raising support via equity or debt offerings. Northern Genesis Acquisition Corp. III, founded in 2021 and headquartered in Kansas City, Missouri, operates principally in the United States and maintains no significant ongoing operations or revenue generation pending a business combination. The company, managed by a team with extensive experience in origination, operations, capital sourcing and governance, completed its initial public offering in March 2021 raising $150 million through 15 million units at $10 per unit and granted underwriters a 45-day option for an additional 2.25 million units; as of late 2025, it reports zero institutional owners, a market capitalization around $219 million, 21.6 million shares outstanding, and no recent mergers, acquisitions, partnerships, new product launches or other major strategic changes within the last two years while retaining approximately 73% institutional shareholder interest and 20% insider ownership.
US Army Awards L3Harris NGC2 Manpack Radio Delivery Orders
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
Northern Graphite (CVE:NGC) Trading 25.7% Higher – Time to Buy?
Northern Graphite (CVE:NGC) Trading 25.7% Higher – Should You Buy?
Northern Graphite (CVE:NGC) Stock Price Up 25.7% – Still a Buy?
Northern Graphite (CVE:NGC) Shares Up 25.7% – Should You Buy?
Northern Graphite (CVE:NGC) Stock Price Up 25.7% – Here’s Why
Northern Graphite (CVE:NGC) Trading 25.7% Higher – What’s Next?
Northern Graphite (CVE:NGC) Stock Price Up 25.7% – Should You Buy?
Northern Graphite (CVE:NGC) Stock Price Up 25.7% – Should You Buy?
Northern Graphite (CVE:NGC) Trading 25.7% Higher – Still a Buy?
Northern Graphite (CVE:NGC) Trading Up 25.7% – Here’s Why
Northern Graphite (CVE:NGC) Shares Up 25.7% – What’s Next?
US Army Selects L3Harris to Support NGC2 Program
Northern Graphite Announces Graphite Price Increase, Mill Restart
Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer
Northern Graphite Awarded Quebec Government Exploration Grant for Lac des Iles
Northern Graphite Comments on U.S. Tariffs on Graphite from China